Press Releases Search News Category Company ReleasesCompany StatementsFinancial ReleasesProduct Releases Year None202320222021202020192018201720162015201420132012201120102009200820072006 Date Title PDF Version May 05, 2020 Alexion to Acquire Portola May 01, 2020 Alexion Receives CHMP Positive Opinion for ULTOMIRIS® (ravulizumab) in Atypical Hemolytic Uremic Syndrome (aHUS) Apr 20, 2020 Alexion Announces Plans to Initiate Phase 3 Study of ULTOMIRIS® (ravulizumab-cwvz) in Hospitalized Patients with Severe COVID-19 Apr 09, 2020 Alexion to Report First Quarter Results and Provide Update on COVID-19 on Wednesday, May 6th, 2020 Apr 01, 2020 Alexion Makes Donations to Support Community Responses to COVID-19 Outbreak Mar 24, 2020 Alexion Statement on SOLIRIS® (eculizumab) and COVID-19 Mar 05, 2020 Alexion Announces Upcoming Data Presentations at 72nd Annual Meeting of the American Academy of Neurology Feb 27, 2020 Alexion Announces Launch of Alexion Charitable Foundation and Calls for Grantees Feb 26, 2020 Alexion to Present at the 40th Annual Cowen Health Care Conference Feb 20, 2020 Alexion to Present at the 9th Annual SVB Leerink Global Healthcare Conference Pagination First page « first Previous page ‹ previous … Page 3 Page 4 Page 5 Page 6 Current page 7 Page 8 Page 9 Page 10 Page 11 … Next page next › Last page last » Displaying 61 - 70 of 626